Carregant...
The case of Kawasaki disease after rituximab infusion triggered by human anti-chimeric antibodies
Rituximab (RTX) is an effective treatment for refractory nephrotic syndrome (NS), but may produce human anti-chimeric antibodies (HACA) which can cause severe infusion reaction or rituximab-induced serum sickness (RISS). RISS presents with a fever, rash, and arthralgia, which typically occurs 7–21 d...
Guardat en:
| Publicat a: | CEN Case Rep |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Singapore
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7502089/ https://ncbi.nlm.nih.gov/pubmed/32535844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-020-00492-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|